81 - Beyond Antibiotics: Vector Control, Phages, Host Directed Therapies

Speaker(s)

• AB

  Amy Barczak, MD

  Assistant Professor
  Massachusetts General Hospital/Harvard Medical School
  Cambridge, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Paul Bollyky, MD/PhD

  Associate Professor
  Stanford University
  Stanford, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  David Edgell, PhD

  Professor
  Western University
  London, ON, Canada

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE Credits

Learning Objectives:

• explain the role of the host response as a therapeutic target in TB
• discuss the potential of CRISPR as an antibiotic strategy
• express the interpaly of bacteriophages in host innate immune activaiton during bacterial infection

Presentations:

• 2:45pm – 4:00pm EDT

  Crispr as an Antibiotic Strategy for Salmonella Infection
  David Edgell, PhD – Western University
• 2:45pm – 4:00pm EDT

  Host Directed Therapies for M. tuberculosis Infection
  Amy K. Barczak, MD – Massachusetts General Hospital/Harvard Medical School
• 2:45pm – 4:00pm EDT

  Phage Therapy and Innate Immune Activation
  Paul L. Bollyky, MD/PhD – Stanford University